📉 $JNJ fell 5.73% despite beating earnings expectations! 💰 Key Numbers: • Revenue: $25.4B 📈 (+5.9% YoY) • Adjusted EPS: $2.59 vs. $2.53 expected ✅ • Pharma revenue: $16.8B (+7.7%) • MedTech: +2.5% operational growth • 2026 adjusted EPS outlook raised to $11.10 🎯 🔻 Why did the stock fall? Investors focused on weaker-than-expected medical device sales for the second consecutive quarter. 🌍 Middle East tensions, European austerity and pricing pressure in China weighed on MedTech performance. ⚖️ Despite the earnings beat and higher guidance, disappointing device sales overshadowed the positives. 📊 Your thoughts: Buying the dip or staying away? 👇
516 views
1 Comments
Leo
@l3onel · 9d
I had em but sold out of em for 18% gain.. good company 🔥
See the full comment section 👀Sign up for the full Blossom experience!
